Biotechnology · Healthcare
Chairman, CEO, Board Member
2023-01-01–present
Chairman
Fortrea Holdings Inc. (FTRE)Board Member
Fortrea Holdings Inc. (FTRE)Equibles does not estimate personal net worth.
Get an email with a short summary when Fortrea Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get FTRE alertsPeter M. Neupert is recorded as Board Member at Fortrea Holdings Inc. (FTRE) since January 1, 2023 and Chairman and CEO at Fortrea Holdings Inc. (FTRE). The newest filing on record that lists Peter M. Neupert as CEO and Board Member at Fortrea Holdings Inc. (FTRE) is dated April 27, 2026. Fortrea Holdings Inc. reported in an 8-K filed May 12, 2025 that Peter M. Neupert was appointed Chair of the Board, effective May 13, 2025. Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Peter M. Neupert was appointed Class III Director. The proxy statement of Fortrea Holdings Inc. reports total compensation of $1,145,261 for Peter M. Neupert in fiscal 2025, including a base salary of $389,423. Peter M. Neupert has spoken on 1 earnings call across 1 company, most recently for Fortrea Holdings Inc. on May 12, 2025. Fortrea Holdings Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fortrea Holdings Inc. includes Anshul Thakral (CEO and Board Member), Thomas Pike (CEO, Chairman and Board Member), Jason F. Knoblauch (CFO) and 7 others.
“Effective May 13, 2025, the Board appointed Mr. Neupert to serve as Chair of the Board, Dr. Amrit Ray to serve as Lead Independent Director, Erin Russell to serve as a member of the Board's Audit Committee, and Machelle Sanders to serve as Chair of the Nominating, Corporate Governance and Compliance Committee.”
“Peter M. Neupert will be appointed to our board of directors in connection with the spinoff.”
“It’s hard to predict when you’re going to land on the right individual to take the business forward. I’d say we’re far along and we’re very optimistic that we will have somebody in the seat in the not-too-distant future.”
2023-01-01–present
Last confirmed April 27, 2026
Start not stated–present
Last confirmed April 27, 2026
Biotechnology · Healthcare
Chairman, CEO, Board Member
2023-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Fortrea Holdings Inc. (FTRE) | CEO | $389,423 | $1,145,261 |